Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, pp.359-86, 2015. ,
Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer, Clin Breast Cancer, vol.16, pp.335-378, 2016. ,
Cancer statistics, CA Cancer J Clin, vol.65, pp.5-29, 2015. ,
Improved survival in metastatic breast cancer 1985-2016, Breast, vol.31, pp.46-50, 2017. ,
Mechanisms of endocrine resistance in breast cancer, Annu Rev Med, vol.62, pp.233-280, 2011. ,
Targeted therapies for breast cancer, J Clin Invest, vol.121, pp.3797-803, 2011. ,
Triple-negative breast cancer, N Engl J Med, vol.363, pp.1938-1986, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02463255
Molecular portraits of human breast tumours, Nature, vol.406, pp.747-52, 2000. ,
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, vol.98, pp.10869-74, 2001. ,
Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc Natl Acad Sci U S A, vol.100, pp.8418-8441, 2003. ,
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, Ann Oncol, vol.24, pp.2206-2229, 2013. ,
Molecular stratification of triple-negative breast cancers, Oncologist, vol.16, pp.61-70, 2011. ,
Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers ,
, Br J Cancer, vol.109, pp.1886-94, 2013.
Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer, Br J Cancer, vol.110, pp.1688-97, 2014. ,
Complexities of androgen receptor signalling in breast cancer, Endocr Relat Cancer, vol.21, pp.161-81, 2014. ,
Identification of molecular apocrine breast tumours by microarray analysis, Oncogene, vol.24, pp.4660-71, 2005. ,
Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15, Breast Cancer Res, vol.15, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00850498
A refined molecular taxonomy of breast cancer, Oncogene, vol.31, pp.1196-206, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00611752
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, J Clin Invest, vol.19, pp.2750-67, 2011. ,
Gene expression profiling predicts clinical outcome of breast cancer, Nature, vol.415, pp.530-566, 2002. ,
Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights, J Natl Cancer Inst, vol.107, 2015. ,
A geneexpression signature as a predictor of survival in breast cancer, N Engl J Med, vol.347, pp.1999-2009, 2002. ,
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer, N Engl J Med, vol.351, pp.2817-2843, 2004. ,
Supervised risk predictor of breast cancer based on intrinsic subtypes, J Clin Oncol, vol.27, pp.1160-67, 2009. ,
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy, J Clin Oncol, vol.31, pp.2783-90, 2013. ,
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer, J Clin Oncol, vol.34, pp.1134-50, 2016. ,
Breast cancer classification and prognosis based on gene expression profiles from a population-based study, Proc Natl Acad Sci U S A, vol.100, pp.10393-98, 2003. ,
Molecular classification of breast cancer: what the pathologist needs to know, Pathology, vol.49, pp.111-130, 2017. ,
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer, N Engl J Med, vol.379, pp.111-132, 2018. ,
Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe, Cancer Treat Rev, vol.62, pp.74-90, 2018. ,
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts, Cell Rep, vol.4, pp.1116-1146, 2013. ,
Activating ESR1 mutations in hormone-resistant metastatic breast cancer, Nat Genet, vol.45, pp.1446-51, 2013. ,
Combinatorial biomarker expression in breast cancer, Breast Cancer Res Treat, vol.120, pp.293-308, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00535436
Molecular signatures in breast cancer, Methods, vol.131, pp.135-181, 2017. ,
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer, J Clin Oncol, vol.31, pp.3997-4013, 2013. ,
, American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 2017.
Micromolecular methods for diagnosis and therapeutic strategy: a case study, Oncotarget, vol.9, pp.22862-69, 2018. ,
Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffinembedded breast carcinoma tissue, Clin Chem, 2013. ,
, , vol.59, pp.991-94
Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples, Exp Mol Pathol, vol.100, pp.287-93, 2016. ,
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches, Br J Cancer, vol.104, pp.1739-1785, 2011. ,
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer, Clin Cancer Res, vol.23, pp.3676-83, 2017. ,
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes, Clin Cancer Res, vol.19, pp.5533-5573, 2013. ,
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis, Lancet Oncol, vol.11, issue.10, pp.70130-70133, 2010. ,
High EGFR gene copy number predicts poor outcome in triple-negative breast cancer, Mod Pathol, vol.27, pp.1212-1234, 2014. ,
Phase II trial of bicalutamide in patients with androgen receptorpositive, estrogen receptor-negative metastatic Breast Cancer, Clin Cancer Res, vol.19, pp.5505-5517, 2013. ,
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1), Ann Oncol, vol.27, pp.812-830, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01791274
Individual xenograft as a personalized therapeutic resort for women with metastatic triple-negative breast carcinoma, Breast Cancer Res, vol.16, p.401, 2014. ,
Individual xenografts for personalized treatment of women with metastatic triple negative breast cancer, Journal of Translational Genetics and Genomics, vol.2, p.19, 2018. ,
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma, Oncotarget, vol.6, pp.19279-89, 2015. ,
Tracking the clonal origin of lethal prostate cancer, J Clin Invest, vol.123, pp.4918-4940, 2013. ,
Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients, Breast Cancer Res Treat, vol.162, pp.11-18, 2017. ,
Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalinfixed paraffin-embedded breast and gastric cancer samples, J Cancer Res Ther, vol.13, pp.730-764, 2017. ,
, Biopsies in oncology. Diagn Interv Imaging, vol.95, pp.647-57, 2014.
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis, PLoS Med, vol.13, p.1002201, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02297451
Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes, Oncotarget, vol.8, pp.37332-37373, 2017. ,
, NCCN NCCN. Genetic/familial high-risk assessmentfor: breast and ovarian (Version 2, p.56, 2019.
, Quels gènes analyser face à un risque de cancer héréditaire du sein et de l'ovaire? 58. UNICANCER. Recommandations de prévention ou dépistage des personnes porteuses d'une mutation d
Next-generation sequencing technologies: breaking the sound barrier of human genetics, Mutagenesis, vol.29, pp.303-313, 2014. ,
, Comprehensive molecular portraits of human breast tumours, Nature, vol.490, pp.61-70, 2012.
Meric-Bernstam F. Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer, Clin Cancer Res, vol.17, pp.1082-89, 2011. ,
Prevalence of BRCA1 and BRCA2 gene mutations in patients with earlyonset breast cancer, J Natl Cancer Inst, vol.91, pp.943-992, 1999. ,
BRCAness: finding the Achilles heel in ovarian cancer, Oncologist, vol.17, pp.956-62, 2012. ,
Basal-like breast cancer: update on clinicopathologic, immunohistochemical, and molecular features, Arch Pathol Lab Med, vol.138, pp.37-43, 2014. ,
Hallmarks of 'BRCAness' in sporadic cancers, Nat Rev Cancer, vol.4, pp.814-833, 2004. ,
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation, N Engl J Med, vol.377, pp.523-556, 2017. ,
Update on PARP Inhibitors in Breast Cancer, Curr Treat Options Oncol, vol.19, 2018. ,
Large-scale genotyping identifies 41 new loci associated with breast cancer risk, Nat Genet, vol.45, pp.361-362, 2013. ,
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer, Nat Genet, vol.47, pp.373-80, 2015. ,
Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells, J Cell Physiol, vol.210, pp.720-751, 2007. ,
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC, Proc Natl Acad Sci U S A, vol.107, pp.9742-9788, 2010. ,
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study, Genet Epidemiol, vol.21, pp.1-18, 2001. ,
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.486, pp.346-52, 2012. ,
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors, Clin Cancer Res, vol.17, pp.6012-6032, 2011. ,
A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer, Clin Cancer Res, vol.14, pp.2601-2609, 2008. ,
,
, Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer, Lancet, vol.365, pp.671-79, 2005.
A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response, Breast Cancer Res Treat, vol.133, pp.37-47, 2012. ,
Gene expression profiles of primary breast www.oncotarget.com tumors maintained in distant metastases, Proc Natl Acad Sci U S A, vol.100, pp.15901-15906, 2003. ,
Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study, Genes Chromosomes Cancer, vol.48, pp.1091-101, 2009. ,
Identification of metastasis-associated breast cancer genes using a highresolution whole genome profiling approach, J Cancer Res Clin Oncol, vol.137, pp.795-809, 2011. ,
Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities, Mol Cancer Ther, vol.12, pp.104-120, 2013. ,
Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer, Oncotarget, vol.6, pp.43731-43773, 2015. ,
Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer, Cancer Lett, vol.362, pp.36-44, 2015. ,
Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy, Clin Cancer Res, vol.21, pp.5371-79, 2015. ,
Expression profiling of circulating tumor cells in metastatic breast cancer, Breast Cancer Res Treat, vol.149, pp.121-152, 2015. ,
Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer, Clin Cancer Res, vol.22, pp.146-57, 2016. ,
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers, Ann Oncol, vol.27, pp.1860-66, 2016. ,
BRCA1-and BRCA2-Associated Hereditary Breast and Ovarian Cancer, 1993. ,
, Online Mendelian Inheritance in Man OJHU, 2018.
, Online Mendelian Inheritance in Man OJHU, vol.600185
Cancer du sein : risque génétique, Imag Femme, vol.26, pp.95-104, 2016. ,
, Online Mendelian Inheritance in Man OJHU
, GeneReviews((R)). (, 1993.
, Online Mendelian Inheritance in Man OJHU, 2018.
Hereditary Diffuse Gastric Cancer, 1993. ,
, , 2018.
, , 1993.
, Online Mendelian Inheritance in Man OJHU, 2018.
, , 1993.
, Online Mendelian Inheritance in Man OJHU
Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients, Clin Genet, vol.88, pp.95-99, 2012. ,
RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families, Springerplus, vol.4, p.92, 2015. ,
Women at high risk of breast cancer: molecular characteristics, clinical presentation and management, Breast, vol.28, pp.136-180, 2016. ,
, Online Mendelian Inheritance in Man OJHU
, , 1993.
, Online Mendelian Inheritance in Man OJHU, 2018.
,
, Online Mendelian Inheritance in Man OJHU, 2018.
, Online Mendelian Inheritance in Man OJHU, vol.600259, pp.12-27
, Online Mendelian Inheritance in Man OJHU